Abatacept Exposure-Response Analysis and its Impact on Dose Selection in Lupus Nephritis

被引：0
|
作者：
Suryawanshi, Satyendra [1 ]
Tagen, Michael [1 ]
Murthy, Bindu [1 ]
Hillson, Jan [1 ]
Roy, Amit [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [1] ABATACEPT EXPOSURE-RESPONSE ANALYSIS AND ITS IMPACT ON DOSE SELECTION IN LUPUS NEPHRITIS
    Suryawanshi, S.
    Tagen, M.
    Murthy, B.
    Hillson, J.
    Roy, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 480 - 480
  • [2] Use of a Biomarker in Exposure-Response Analysis to Support Dose Selection for Fingolimod
    Lee, J-Y
    Wang, Y.
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2013, 2 (08):
  • [3] Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of Palbociclib
    Jenny Zheng
    Yanke Yu
    Chandrasekar Durairaj
    Véronique Diéras
    Richard S. Finn
    Diane D. Wang
    [J]. Targeted Oncology, 2021, 16 : 69 - 76
  • [4] Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of Palbociclib
    Zheng, Jenny
    Yu, Yanke
    Durairaj, Chandrasekar
    Dieras, Veronique
    Finn, Richard S.
    Wang, Diane D.
    [J]. TARGETED ONCOLOGY, 2021, 16 (01) : 69 - 76
  • [5] ABATACEPT POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE ANALYSES FOR DOSE RECOMMENDATION OF SC AND IV ABATACEPT IN PATIENTS WITH PSORIATIC ARTHRITIS.
    Li, X.
    Passarell, J. A.
    Morris, D.
    Murthy, B.
    Girgis, I. G.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S77 - S77
  • [6] Exposure-response analysis for selection of optimal dosage regimen of anifrolumab in patients with systemic lupus erythematosus
    Chia, Yen Lin
    Santiago, Linda
    Wang, Bing
    Kuruvilla, Denison
    Wang, Shiliang
    Tummala, Raj
    Roskos, Lorin
    [J]. RHEUMATOLOGY, 2021, 60 (12) : 5854 - 5862
  • [7] Mycophenolic Acid Exposure In Lupus Nephritis To Standard Clinical Dose And Its Correlation To Therapeutic Response
    Pattanaik, Smita
    Panwar, Ritika
    Singh, Sheetal
    Naithani, Priyanka
    Dey, Sumit
    Sharma, Aman
    Rathi, Manish
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 365 - 365
  • [8] Exposure-Response Analysis for Selection of Optimal Dosage Regimen of Anifrolumab in Patients with Systemic Lupus Erythematosus
    Santiago, L.
    Wang, B.
    Brohawn, P.
    Wang, L.
    Illei, G.
    Roskos, L.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] CHARACTERIZATION OF ABATACEPT PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIP IN SUPPORT OF SUBCUTANEOUS DOSE FOR JAPANESE RHEUMATOID ARTHRITIS
    Hasegawa, M.
    Roy, A.
    Imai, Y.
    Hiraoka, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S45 - S45
  • [10] Exposure-response analysis of tezepelumab in patients with severe asthma to guide phase 3 dose selection
    Ly, Neang
    Zheng, Yanan
    Griffiths, Janet M.
    Van der Merwe, Rene
    Agoram, Balaji
    Roskos, Lorin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345